2796 — Pharmarise Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMicro CapNeutral

Annual balance sheet for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st	2026 May 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3,991	4,742	7,150	4,911	6,012
Net Total Accounts Receivable
Net Total Receivables	4,265	4,017	3,553	3,781	3,741
Total Inventory
Total Other Current Assets
Total Current Assets	10,878	11,372	13,737	13,239	13,164
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,355	6,010	6,198	7,209	7,621
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	23,746	23,421	29,486	31,924	32,680
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,477	9,835	10,688	11,988	14,010
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	17,138	16,539	22,124	25,055	25,838
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,608	6,882	7,362	6,869	6,842
Total Liabilities & Shareholders' Equity	23,746	23,421	29,486	31,924	32,680
Total Common Shares Outstanding